Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • NPPA issues notices to...

    NPPA issues notices to drug cos for not registering under DPCO 2013

    Written by savita thakur thakur Published On 2016-06-14T12:15:38+05:30  |  Updated On 14 Jun 2016 12:15 PM IST
    NPPA issues notices to drug cos for not registering under DPCO 2013

    New Delhi : Taking a serious view of non-compliance of DPCO, 2013, the National Pharmaceutical Pricing Authority (NPPA) has issued notices to major drug firms for failing to register products on online database IPDMS and not filing mandatory returns through it.


    The authority also plans to issue notices to other firms as well that have not furnished information so far.


    "We have issued notices to top 10 firms that have not registered their products under IPDMS and will be also be issuing notices to others," NPPA Chairman Bhupendra Singh said.


    NPPA had asked all pharma firms to register themselves with the Integrated Pharmaceutical Database Management System (IPDMS) in September 2014 and had extended the last date to submit the requisite information repeatedly.


    The authority has issued many price notifications, especially during March-June 2016, but many pharma companies have not submitted the forms as required under DPCO, 2013, in IPDMS, NPPA said in a notice on its website.


    NPPA has taken a serious view about the willful violation of the Drug Prices Control Order (DPCO), 2013, by some of the companies, it added.


    "In this regard, NPPA is now constrained to issue show-cause notices to individual companies for not having their pharmaceutical products under IPDMS and not having filed mandatory returns in form II, III and V through IPDMS," it added.


    Toughening the stance, it added that "NPPA shall also be constrained to take necessary legal action against the companies including exercises of its powers under para 29, para 30 of DPCO 2013, including prosecution under the EC Act under unavoidable circumstances". Form II is submitted for revised prices for scheduled formulations while Form V is to be filed for all formulations under IPDMS after registration.


    The pricing regulator has also asked industry associations to sensitise their members on this compliance urgently.


    NPPA had asked all pharmaceutical firms to register themselves under IPDMS for online filing of returns for monitoring, fixing and revision of drug prices.

    Bhupendra SinghDPCODrug Prices Control OrderIntegrated Pharmaceutical Database Management SystemIPDMSIssued noticesNational Pharmaceutical Pricing AuthorityNPPA
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok